Empresas y finanzas

Gilead Announces Departure of Caroline Dorsa



    Gilead Sciences, Inc. (Nasdaq:GILD) today announced that Caroline
    Dorsa has resigned from her position as Chief Financial Officer (CFO),
    a role she assumed in November 2007, to pursue another opportunity.

    Gilead plans to initiate a search to identify a new CFO. In the
    interim, John F. Milligan, PhD, Gilead´s Chief Operating Officer, will
    reassume the additional responsibilities of CFO - a position he held
    from 2003 until 2007 - effective immediately.

    About Gilead Sciences

    Gilead Sciences is a biopharmaceutical company that discovers,
    develops and commercializes innovative therapeutics in areas of unmet
    medical need. The company´s mission is to advance the care of patients
    suffering from life-threatening diseases worldwide. Headquartered in
    Foster City, California, Gilead has operations in North America,
    Europe and Australia.

    For more information on Gilead, please call the Gilead Public
    Affairs Department at 1-800-GILEAD-5 (1-800-445-3235) or visit
    www.gilead.com.